EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2025 (TTM): $0.13

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is $0.13. In 2024 the company made an earnings per share (EPS) of $0.14 an increase over its 2023 EPS that were of $0.09620.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2025

Annual EPS

Year	EPS	Change
2025 (TTM)	$0.13	-6.54%
2024	$0.14	42.43%
2023	$0.09620	8.77%
2022	$0.08845	-20.62%
2021	$0.11	-26.59%
2020	$0.15	27.24%
2019	$0.12	28.41%
2018	$0.09290	20.04%
2017	$0.07739	31.21%
2016	$0.05898	11.46%
2015	$0.05292	36.27%
2014	$0.03883	19.77%
2013	$0.03242	18.05%
2012	$0.02746	23.9%
2011	$0.02217	26.9%
2010	$0.01747	12.37%
2009	$0.01555	56.6%
2008	$0.009927	9.18%
2007	$0.009092	114.48%
2006	$0.004239	64.83%
2005	$0.002572	35.55%
2004	$0.001897	29.73%
2003	$0.001463	19.86%
2002	$0.001220	-2.71%
2001	$0.001254	1.02%
2000	$0.001242

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions